Here’s a concise mechanistic read of why SNU61 is hypersensitive to RB1CC1 loss, tying its dependency profile to its mutations, with references.

Summary in one line
- SNU61 appears “autophagy‑addicted.” RB1CC1 (FIP200) is the scaffold of the ULK1–ATG13–ATG101 complex that nucleates autophagosomes, and this line’s top dependencies (ATG9A, ATG12, BIRC6, UBE2Z) plus its KRASG12D/TP53/APC/PIK3R1 genotype all point to a state where shutting off RB1CC1 collapses the autophagy that SNU61 needs to buffer oncogenic and metabolic stress. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19258318/?utm_source=openai))

1) What RB1CC1/FIP200 does
- RB1CC1 is the core scaffold of the mammalian autophagy initiation complex; it binds ULK1/2 and ATG13, integrates mTOR signaling, and is essential for autophagosome biogenesis. Loss of FIP200 blocks early autophagy steps. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19258318/?utm_source=openai))
- RB1CC1 also directly engages selective‑autophagy receptors (e.g., TAX1BP1, NDP52, p62) through a C‑terminal “Claw/FIR” interaction surface, allowing receptor‑decorated cargo to recruit the ULK complex and trigger local autophagosome formation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30853402/?utm_source=openai))

2) The dependency profile screams “autophagy”
- ATG9A and ATG12 are in SNU61’s top dependencies; both are core autophagy proteins required for phagophore growth (ATG9A vesicle trafficking/lipid scrambling) and LC3 lipidation (ATG12–ATG5 E3‑like conjugation complex). Co‑dependency on these strongly indicates survival requires intact macroautophagy. ([nature.com](https://www.nature.com/articles/s41421-020-0161-3?utm_source=openai))
- BIRC6 (BRUCE) sits high as well. BIRC6 regulates late autophagy (reported to support autophagosome–lysosome fusion) and/or restrains autophagy by ubiquitinating LC3B, and it also inhibits apoptosis by ubiquitinating SMAC and caspase‑9. Its essentiality in SNU61 is consistent with heavy flux through autophagy and strong pressure to suppress apoptosis. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6103727/?utm_source=openai))
- UBE2Z (USE1), another top hit, is the UBA6‑specific E2 in the ubiquitin/FAT10 branch that intersects with proteostasis; the UBA6–BIRC6 axis was shown to control LC3B levels. Together with BIRC6, this suggests SNU61 relies on tightly tuned ubiquitin/autophagy crosstalk. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6539292/?utm_source=openai))

3) SNU61’s genotype favors autophagy dependence
- Identity/context: SNU61 is a colorectal carcinoma (liver metastasis–derived) line carrying APC p.R1450Ter and KRAS p.G12D—canonical CRC lesions. ([cellosaurus.org](https://www.cellosaurus.org/CVCL_5078?utm_source=openai))
- KRAS‑mutant tumors often require autophagy for mitochondrial function and metabolic fitness; genetic ablation of essential autophagy genes (e.g., Atg7) in KrasG12D lung models arrests tumor growth, shifts tumors to benign oncocytomas, and creates glutamine and FAO liabilities—phenotypes of “autophagy addiction.” That biology provides a direct rationale for why RB1CC1 (autophagy initiation) knockout is catastrophic. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23959381/?utm_source=openai))
- TP53 is mutant (R175H). In Kras‑driven settings with p53 loss, autophagy becomes even more critical to sustain FAO and lipid metabolism, again predicting sensitivity when autophagy is shut off upstream at RB1CC1. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3713426/?utm_source=openai))
- PIK3R1 is truncated (p.W597Ter). Loss‑of‑function alterations in PIK3R1 generally relieve negative control on PI3K and can sustain AKT/mTOR signaling—driving anabolic load and proteotoxic/energetic stress that cells offset via autophagy. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9438279/?utm_source=openai))
- Additional stressors may intensify dependence on mitophagy/autophagy: PRDX1 splice‑site alteration (reduced antioxidant buffering elevates ROS burden), and an ACADM missense/splice‑region variant (potentially impairing medium‑chain FAO), both of which converge on mitochondrial quality control and lipid metabolism—processes supported by autophagy in KRAS tumors. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/29773556/?utm_source=openai))

4) A receptor–scaffold angle that further implicates RB1CC1
- SNU61 carries TAX1BP1 p.D308V. TAX1BP1 is a selective‑autophagy receptor that binds RB1CC1 via its SKICH and coiled‑coil regions to cluster FIP200 at cargo and nucleate autophagosomes—even in contexts that can bypass parts of the LC3 lipidation machinery. A missense change within the coiled‑coil region could plausibly perturb this wiring, making the integrity of RB1CC1 itself even more rate‑limiting for selective autophagy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/38437556/?utm_source=openai))
  - Mechanistically, TAX1BP1/NDP52 recruit the ULK complex to cargo through direct RB1CC1 binding; phosphorylation‑regulated FIR/Claw interactions fine‑tune this step. If the receptor side is suboptimal, cells may rely on higher RB1CC1 dosage/scaffolding to sustain cargo‑initiated autophagosome formation—raising sensitivity to RB1CC1 loss. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30853402/?utm_source=openai))

5) Coherence check with literature on RB1CC1 loss in autophagy‑dependent cancer cells
- In highly autophagy‑dependent cancer cells, RB1CC1/FIP200 or ATG7 knockout acutely suppresses growth; rare survivors adapt by activating NRF2. This is exactly the phenotype you’d expect if RB1CC1 were the single most leveraged node. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32160093/?utm_source=openai))

6) Putting it together: why SNU61 is super sensitive to RB1CC1 KO
- The line harbors oncogenic KRAS with mutant TP53 and truncal APC, and it likely runs high proteotoxic/oxidative/metabolic stress. Its strongest dependencies include RB1CC1, ATG9A, ATG12 and BIRC6/UBE2Z—an autophagy/ubiquitin signature. Removing RB1CC1 disables the ULK–FIP200 scaffold that initiates both bulk and selective autophagy, cutting off the cell’s primary stress‑buffering route and causing a fitness crash. A TAX1BP1 coiled‑coil mutation could further funnel reliance onto intact RB1CC1‑mediated recruitment of the ULK complex. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19258318/?utm_source=openai))

Practical checks you can run to confirm the mechanism
- Phenocopy with orthogonal autophagy hits: CRISPR KO or siRNA of ATG13, ATG101, ULK1/2, or ATG7/ATG5; expect similar loss of fitness and LC3‑flux blockade, with p62/SQSTM1 accumulation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19258318/?utm_source=openai))
- Pharmacology: ULK1/2 or VPS34 inhibitors should suppress growth/viability more than late‑stage lysosomotropics (which can have off‑target effects). Combine with ROS quenchers (e.g., NAC) to test whether redox stress contributes to lethality. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3713426/?utm_source=openai))
- Selective‑autophagy readouts: test mitophagy and aggrephagy markers after RB1CC1 KO and after TAX1BP1 overexpression/CRISPR base‑editing reversion of D308V to see if FIP200–receptor engagement is rate‑limiting. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33226137/?utm_source=openai))

Notes on the cell line context
- SNU61’s identity and key driver lesions are well documented in Cellosaurus and CRC databases (APC R1450Ter; KRAS G12D), consistent with a colorectal origin prone to Wnt and RAS pathway stress—settings where autophagy is frequently co‑opted. ([cellosaurus.org](https://www.cellosaurus.org/CVCL_5078?utm_source=openai))

References
- ULK–ATG13–FIP200 complex essential for autophagy initiation and mTOR regulation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19258318/?utm_source=openai))
- FIP200/Claw interactions with selective‑autophagy receptors (TAX1BP1/NDP52/p62) and receptor‑driven clustering of FIP200 to initiate autophagosome formation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30853402/?utm_source=openai))
- ATG9A function in autophagosome biogenesis; ATG12 conjugation system’s role in LC3 lipidation. ([nature.com](https://www.nature.com/articles/s41421-020-0161-3?utm_source=openai))
- BIRC6 as autophagy regulator and anti‑apoptotic E2/E3; UBA6–BIRC6 control of LC3B. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6103727/?utm_source=openai))
- KRAS‑driven tumors’ autophagy dependency (Atg7 deletion studies); intensification with TP53 loss. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23959381/?utm_source=openai))
- PIK3R1 loss‑of‑function activates PI3K/AKT signaling, increasing anabolic stress; review and functional data. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9438279/?utm_source=openai))
- SNU61 identity and driver mutations (APC, KRAS). ([cellosaurus.org](https://www.cellosaurus.org/CVCL_5078?utm_source=openai))
- RB1CC1/ATG7 KO suppresses growth in autophagy‑dependent cancer cells with NRF2 escape as a rare adaptation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32160093/?utm_source=openai))

If you want, I can map each listed SNU61 mutation to specific autophagy/metabolic axes (e.g., which ones heighten ROS, ER stress, FAO defects) and propose a minimal experiment panel to validate each contribution.